PAVmed (PAVM) Depreciation & Amortization (CF) (2016 - 2025)

PAVmed's Depreciation & Amortization (CF) history runs 10 years deep, the most recent figure standing at $18000.0 for Q4 2025.

• On a quarterly basis, Depreciation & Amortization (CF) fell 73.91% year-over-year to $18000.0 in Q4 2025; TTM through Dec 2025 was $105000.0, a 89.06% decrease from a year earlier, with the FY2025 full-year figure at $105000.0, down 91.24% from the prior year.
• Depreciation & Amortization (CF) declined to $18000.0 in Q4 2025 per PAVM's latest filing, from $22000.0 in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $815000.0 in Q2 2022 and bottomed at $10000.0 in Q2 2021.
• The 5-year median for Depreciation & Amortization (CF) is $216000.0 (2022), against an average of $351263.2.
• Across the five-year window, Depreciation & Amortization (CF) surged 8050.0% in 2022 and tumbled 92.79% in 2025, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $166000.0 in 2021, then surged by 337.35% to $726000.0 in 2022, then decreased by 0.14% to $725000.0 in 2023, then plunged by 90.48% to $69000.0 in 2024, then sank by 73.91% to $18000.0 in 2025.
• Per Business Quant, the three latest PAVM Depreciation & Amortization (CF) figures stand at $18000.0 (Q4 2025), $22000.0 (Q3 2025), and $22000.0 (Q2 2025).